Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.9B | 2.2B | 2.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 523M | 584M | 479M | 535M |
Operating income | 329M | 178M | 76M | 172M |
Non operating interest income | ||||
Income | 23M | 23M | 20M | 18M |
Expense | 19M | 22M | 23M | 14M |
Other income expense | — | — | — | — |
Pretax income | 333M | 181M | 71M | 176M |
Tax provision | 75M | -23M | 18M | 37M |
Net income | 257M | 203M | 53M | 138M |
Basic EPS | 0.9 | 0.7 | 0.2 | 0.5 |
Diluted EPS | 0.9 | 0.7 | 0.2 | 0.5 |
Basic average shares | 301.4M | 295.5M | 288.4M | 286.0M |
Diluted average shares | 302.4M | 295.8M | 301.2M | 296.8M |
EBITDA | 477M | 332M | 215M | 310M |
Net income from continuing op. | 333M | 181M | 71M | 176M |
Minority interests | 0 | -1M | -2M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |